2 withdrawn. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Withdrawn 2 |
| Phase 1 | 1 | Withdrawn 1 |
Follow orteronel: new trials by email Literature Review of orteronel trials Research Report on orteronel
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase Ib/II Study Evaluating Orteronel (Without Prednisone) Combined With Itraconazole In Men With Castration-Resistant Prostate Cancer (CRPC) Itraconazole, Orteronel - Prostate Cancer, Castration-resistant Prostate Cancer | Phase 1 / Phase 2 | Withdrawn | Emmanuel Antonarakis, MD | 2014-06-01 | 2014-07-23 | |
| TAK-700 in Castration Resistant Prostate Cancer Orteronel, Bicalutamide - Prostate Cancer | Phase 2 | Withdrawn | European Organisation for Research and Treatment of Cancer - EORTC | 2014-01-01 | 2016-06-10 |
Neoplasm Metastasis (2) · Prostatic Neoplasms (2)
Emmanuel Antonarakis, MD (1) · European Organisation for Research and Treatment of Cancer - EORTC (1)
Belgium (1) · United States (1)
Bertrand Tombal (1) · Cora Sternberg (1)